- Previous Close
1.770 - Open
1.740 - Bid 1.680 x --
- Ask 1.760 x --
- Day's Range
1.680 - 1.740 - 52 Week Range
0.620 - 2.890 - Volume
11,000 - Avg. Volume
44,964 - Market Cap (intraday)
2.726B - Beta (5Y Monthly) 0.00
- PE Ratio (TTM)
8.00 - EPS (TTM)
0.210 - Earnings Date --
- Forward Dividend & Yield 0.12 (7.02%)
- Ex-Dividend Date Jul 15, 2024
- 1y Target Est
--
IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance and repair, installation, and end customer training services. In addition, it researches, develops, manufactures, and sells IVD analyzers and reagents. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. IVD Medical Holding Limited was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.
www.ivdholding.com815
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1931.HK
View More
Performance Overview: 1931.HK
Trailing total returns as of 3/10/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1931.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1931.HK
View MoreValuation Measures
Market Cap
2.87B
Enterprise Value
2.05B
Trailing P/E
8.57
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.73
Price/Book (mrq)
0.79
Enterprise Value/Revenue
0.62
Enterprise Value/EBITDA
5.04
Financial Highlights
Profitability and Income Statement
Profit Margin
8.50%
Return on Assets (ttm)
5.00%
Return on Equity (ttm)
7.85%
Revenue (ttm)
3.06B
Net Income Avi to Common (ttm)
260.44M
Diluted EPS (ttm)
0.210
Balance Sheet and Cash Flow
Total Cash (mrq)
1.63B
Total Debt/Equity (mrq)
23.86%
Levered Free Cash Flow (ttm)
61.81M
Company Insights: 1931.HK
1931.HK does not have Company Insights